Correlation Between Pluri and Corvus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Pluri and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pluri and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pluri Inc and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Pluri and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pluri with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pluri and Corvus Pharmaceuticals.

Diversification Opportunities for Pluri and Corvus Pharmaceuticals

-0.68

Correlation Coefficient

Pluri  Corvus Pharmaceuticals

Excellent diversification

The 3 months correlation between Pluri and Corvus is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Pluri Inc and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Pluri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pluri Inc are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Pluri i.e., Pluri and Corvus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pluri and Corvus Pharmaceuticals

Given the investment horizon of 90 days Pluri is expected to generate 4.25 times less return on investment than Corvus Pharmaceuticals. In addition to that, Pluri is 1.17 times more volatile than Corvus Pharmaceuticals. It trades about 0.05 of its total potential returns per unit of risk. Corvus Pharmaceuticals is currently generating about 0.24 per unit of volatility. If you would invest  578.00  in Corvus Pharmaceuticals on August 15, 2024 and sell it today you would earn a total of  291.00  from holding Corvus Pharmaceuticals or generate 50.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Pluri Inc  vs.  Corvus Pharmaceuticals

Pluri Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pluri Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Pluri is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Corvus Pharmaceuticals

Risk-Adjusted Performance

23 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pluri and Corvus Pharmaceuticals

The main advantage of trading using opposite Pluri and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pluri position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.

The idea behind Pluri Inc and Corvus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.